(A) Expression levels of our hits in M229 melanoma cells during the BRAFi-resistance acquisition. P: parental cells, 2D: two days of treatment, DTP: drug tolerant persister cells, DTPP: drug tolerant proliferating persister cells, SDR: single-drug resistant cells (BRAFi) (B) Expression levels of our hits in M238 melanoma cells during the BRAFi-resistance acquisition. (C) Expression levels of our hits in parental, single drug resistant (SDR, BRAFi) or dual drug resistant (DDR, BRAFi+MEKi) SKMel28 melanoma cell lines 